transfluthrin
Small moleculeexperimental
Transfluthrin is a fast-acting pyrethroid insecticide with low persistency. It has the molecular formula C15H12Cl2F4O2. — Wikipedia
Clinical trial activity
2 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
1
Phase 4
0
Earliest trial started Jun 30, 2015 (NCT03553277)
Timeline
2020s
- Jan 1, 2023
Earliest Phase 3 Sponsor(trial)
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaTransfluthrin ↗
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06179732 | Phase 3 | Jun 5, 2023 | The Mentor Initiative, University of Liverpool |
| NCT03553277 | N/A | Jun 30, 2015 | University of California, Davis, University of Notre Dame Australia |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| The Mentor Initiative | Academic/Hospital | 1 | 1 | 1 | 2023 |
| University of California, Davis | Academic/Hospital | 1 | 0 | 1 | 2015 |
| University of Liverpool | Academic/Hospital | 1 | 0 | 1 | 2023 |
| University of Notre Dame Australia | Academic/Hospital | 1 | 1 | 1 | 2015 |
4 organizations
Page 1 / 1